The IND Application Process Demystified: Essential Guide for Startups
For biotech and pharmaceutical startups, submitting an IND (Investigational New Drug) application to the FDA marks a critical step toward initiating clinical trials and bringing new therapies to market. However, the IND application process can be complex, especially for startups navigating regulatory requirements for the first time. At BioBoston Consulting, we specialize in simplifying this […]
Preclinical Data for IND Applications: How to Build a Strong Case for FDA Review
Before your investigational drug can be tested in humans, the FDA requires compelling preclinical data to support your IND (Investigational New Drug) application. This data must demonstrate that your compound is reasonably safe for initial clinical trials. For biotech startups and early-stage developers, understanding how to generate and present the right preclinical package is crucial […]